Citigroup »

Apellis Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2M 87k 59.86
2023-09-30 $6.7M 177k 38.05
2023-03-31 $11M 173k 65.93
2022-12-31 $6.8M 132k 51.71
2022-09-30 $11M 168k 67.80
2021-12-31 $5.7M 120k 47.28
2021-03-31 $4.2M 98k 42.91
2020-12-31 $5.4M 95k 57.20
2020-09-30 $278k 9.2k 30.19
2020-06-30 $2.2M 68k 32.66
2020-03-31 $1.4M 52k 26.79
2019-12-31 $2.5M 81k 30.62
2019-09-30 $864k 36k 24.04
2019-06-30 $1.2M 47k 25.33
2019-03-31 $458k 24k 19.51
2018-12-31 $672k 51k 13.20
2018-09-30 $842k 48k 17.71
2018-06-30 $599k 27k 22.00
2018-03-31 $0 20 0.00
2017-12-31 $26k 1.2k 21.28